Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CYTOF/Return on equity

Altamira Therapeutics Ltd. (CYTOF) Return on equity

Altamira Therapeutics Ltd. (CYTOF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to CYTOF

Source: SEC XBRL filings · For reference only · Not investment advice

More CYTOF financial trends

CYTOF RevenueCYTOF Net incomeCYTOF Net marginCYTOF Gross profitCYTOF Gross marginCYTOF Operating incomeCYTOF Operating marginCYTOF Operating cash flowCYTOF Free cash flowCYTOF Capital expendituresCYTOF Stock buybacksCYTOF Dividends paidCYTOF Total assetsCYTOF Total liabilitiesCYTOF Shareholders’ equityCYTOF overview →